The historical rank and industry rank for Cytek Biosciences's Price-to-Tangible-Book or its related term are showing as below:
CTKB'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.2 Med: 3.28 Max: 7.12
Current: 1.2
During the past 6 years, Cytek Biosciences's highest Price to Tangible Book Ratio was 7.12. The lowest was 1.20. And the median was 3.28.
CTKB's Price-to-Tangible-Book is ranked better than 81.65% of 703
companies
in the Medical Devices & Instruments industry
Industry Median: 2.74
vs CTKB: 1.20
Cytek Biosciences Price-to-Tangible-Book Historical Data
The historical data trend for Cytek Biosciences's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cytek Biosciences's Price-to-Tangible-Book
For the Medical Devices subindustry, Cytek Biosciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cytek Biosciences's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cytek Biosciences's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Cytek Biosciences's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Cytek Biosciences Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Cytek Biosciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CTKB has been successfully added to your 